Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Oral Leukoplakia
Status:
Terminated
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
This phase I trial studies the side effects and best dose of photodynamic therapy using
aminolevulinic acid in treating patients with oral leukoplakia. Photodynamic therapy uses a
drug, such as aminolevulinic acid, that becomes active when it is exposed to a certain kind
of light. When the drug is active, abnormal cells are killed. Photodynamic therapy using
aminolevulinic acid may be effective against oral leukoplakia.